Russia has completed clinical trials of a second potential vaccine against Covid-19, developed by Siberia's Vector Institute, the RIA news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Wednesday. Earlier this month, this second Covid-19 vaccine, which has been named ‘EpiVacCorona,' has completed early-stage human trials few weeks back, according to reports. The watchdog added that all the volunteers taking part in the clinical trials of the Covid-19 vaccine are feeling fine. Meanwhile, Russia also expects to register a second vaccine by 15 October, a news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying. Russia has registered 8,481 COVID-19 cases in the past 24 hours, bringing the cumulative case total to 1,176,286, the coronavirus response centre said on Wednesday.

Source: Mint September 30, 2020 11:37 UTC